<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Cancer stem cell niche as a therapeutic target</title>
	<atom:link href="http://hematopoiesis.info/2009/12/27/cancer-stem-cell-niche-as-a-therapeutic-target/feed/" rel="self" type="application/rss+xml" />
	<link>http://hematopoiesis.info/2009/12/27/cancer-stem-cell-niche-as-a-therapeutic-target/</link>
	<description>Blood Stem Cell &#38; Cell Therapy Trends</description>
	<lastBuildDate>Fri, 20 Jan 2012 01:41:14 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.1</generator>
	<item>
		<title>By: Joanna</title>
		<link>http://hematopoiesis.info/2009/12/27/cancer-stem-cell-niche-as-a-therapeutic-target/#comment-12187</link>
		<dc:creator>Joanna</dc:creator>
		<pubDate>Mon, 28 Dec 2009 00:56:42 +0000</pubDate>
		<guid isPermaLink="false">http://hematopoiesis.info/?p=1189#comment-12187</guid>
		<description>A little irrelevant, there&#039;s a recent article that discusses how HIF2 is a central axis common to many tumor types (http://www.pnas.org/content/106/50/21306.short?rss=1). Seems like drugs that target this TF will be particularly potent. HIF2 is of course differentially expressed from HIF1. I don&#039;t have a lot of knowledge about HIF1. Is HIF1 a common axis in blood disorders? If so, it&#039;s a better target than others for drug development.</description>
		<content:encoded><![CDATA[<p>A little irrelevant, there&#8217;s a recent article that discusses how HIF2 is a central axis common to many tumor types (<a href="http://www.pnas.org/content/106/50/21306.short?rss=1" rel="nofollow">http://www.pnas.org/content/106/50/21306.short?rss=1</a>). Seems like drugs that target this TF will be particularly potent. HIF2 is of course differentially expressed from HIF1. I don&#8217;t have a lot of knowledge about HIF1. Is HIF1 a common axis in blood disorders? If so, it&#8217;s a better target than others for drug development.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

